Výsledky vyhledávání - "Nancy Bermal"

Safety and immunogenicity of rabies pre- and postexposure intradermal regimens using Abhayrab, a purified vero cell rabies vaccine (PVRV) produced in India in healthy volunteers: towards greater affordability of rabies prophylaxis

Autor: Plebeian Medina, Nancy Bermal, Rio L. Magpantay, Beatriz P. Quiambao

Publikováno v: Asian Biomedicine. 4:61-67

Background: Rabies is 100% fatal, but is preventable. However, due to the high cost of vaccines and immunoglobulins, as well as their limited availability, many dog-bite victims in the Philippines do not complete the required PEP regimen. This concer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc7c06b2f68608531b9b5b90be13d6c3
https://doi.org/10.2478/abm-2010-0007

Zobrazit plný text záznamu

A new DTPw-HBV/Hib vaccine: Immune memory after primary vaccination and booster dosing in the second year of life

Autor: Hans L. Bock, Salvacion Gatchalian, Inge Lefevre, Htay Htay Han, Nancy Bermal, Vijayalakshmi Chandrasekaran, Marietta Reyes

Publikováno v: Human Vaccines. 4:60-66

The response to booster vaccination at 15-18 months of age and the presence of immune memory in 10-month old children, primed with a new combined diphtheria-tetanus-hepatitis B-whole cell pertussis vaccine extemporaneously mixed with Haemophilus infl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399299d0f38e639624c0b1e3f51d4353
https://doi.org/10.4161/hv.4.1.5069

Zobrazit plný text záznamu

IMMUNOGENICITY AND SAFETY OF A VARICELLA VACCINE (OKAVAX™) AND A TRIVALENT MEASLES, MUMPS, AND RUBELLA VACCINE (TRIMOVAX™) ADMINISTERED CONCOMITANTLY IN HEALTHY FILIPINO CHILDREN 12–24 MONTHS OLD

Autor: Nancy Bermal, Salvacion Gatchalian, Didier Leboulleux, Eric Desauziers, Charissa Fay Corazon B. Tabora

Publikováno v: The American Journal of Tropical Medicine and Hygiene. 70:273-277

The immunogenicity and safety of Okavax trade mark varicella vaccine, when administered concomitantly with Trimovax trade mark measles, mumps, and rubella (MMR) vaccine, were assessed in 300 Filipino children 12-24 months old. Three groups received O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320740758a782a8d00b1e5c040b4f3ce
https://doi.org/10.4269/ajtmh.2004.70.273

Zobrazit plný text záznamu

Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults

Autor: Tzou Yien Lin, Ashish P. Dubey, Li-Min Huang, Nancy Bermal, Jacqueline M. Miller, Ashish Bavdekar, Veronique Bianco, Hermant Jain, Yaela Baine

Publikováno v: Human vaccines. 7(2)

The highest incidence of invasive meningococcal disease is in young children, with a second peak in adolescents/young adults. All five major disease-causing serogroups (A, B, C, W-135 and Y) have been described in Asia. Immunogenicity and safety of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0843b2541f5fd236cf04269c960fae91
https://pubmed.ncbi.nlm.nih.gov/21343698

Zobrazit plný text záznamu

Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with DTPw-HBV/Hib and poliovirus vaccines

Autor: Edison Alberto, Leszek Szenborn, Aurélie Fanic, Ilse Dieussaert, Nancy Bermal, Lode Schuerman, Salvacion Gatchalian, Jerzy Pejcz, Ewa Majda-Stanisławska, Marina Hernandez

Publikováno v: The Pediatric infectious disease journal. 30(1)

The safety and reactogenicity profiles of the 10-valent pneumococcal conjugate vaccine, PHiD-CV, and 7vCRM were comparable within the Philippines and Poland when coadministered as a booster dose with DTPw-HBV/Hib and poliovirus vaccines to toddlers p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84285bb7650b29e7f2ff388d3b60e76d
https://pubmed.ncbi.nlm.nih.gov/20980933

Zobrazit plný text záznamu

The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity

Autor: Ilse Dieussaert, Andrzej Chrobot, Lode Schuerman, Nancy Bermal, Edison Alberto, Patricia Lommel, Salvacion Gatchalian, Leszek Szenborn

Publikováno v: The Pediatric infectious disease journal. 28

Background Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) was evaluated when coadministered with DTPw-HBV/Hib and OPV at 6, 10, and 14 weeks of age in the Philippines, or with DT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4aef98b5eb955692ce3e0ccf94a370f
https://pubmed.ncbi.nlm.nih.gov/19325451

Zobrazit plný text záznamu

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines

Autor: Bertrand Chevallier, Javier Arístegui, Patricia Lommel, Timo Vesikari, Nancy Bermal, Dorota Borys, Markus Knuf, Lode Schuerman, Jerzy Brzostek, Jan Cleerbout

Publikováno v: The Pediatric infectious disease journal. 28

Background: Licensed pneumococcal conjugate vaccine (7vCRM) is usually coadministered with combination vaccines in pediatric immunization programs. Reactogenicity and safety after primary and booster vaccination with a novel 10-valent pneumococcal no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a882dc8220aaf577424a293a22bae12
https://pubmed.ncbi.nlm.nih.gov/19325447

Zobrazit plný text záznamu

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)

Autor: Markus Knuf, Christian Petit, Masnuel Moro, Ilse Dieussaert, Nancy Bermal, Leszek Szenborn, Laurence Bernard, Lode Schuerman

Publikováno v: The Pediatric infectious disease journal. 28

Background The choice of non-typeable Haemophilus influenzae Protein D as main carrier protein in the candidate 10-valent pneumococcal conjugate vaccine (PHiD-CV, GlaxoSmithKline Biologicals), was driven in part to avoid carrier-mediated suppression

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5babef1b459533e6438807d2652740e2
https://pubmed.ncbi.nlm.nih.gov/19325452

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání